Skip to main content
Top

Arthritis Research & Therapy

Issue Special Issue 1/2004

24th European Workshop for Rheumatology Research

Content (106 Articles)

Meeting abstract

Prothrombin fragment F1+2 in patients with antiphospholipid antibodies

A Ambrozic, B Bozic, S Cucnik, T Kveder, B Rozman

Meeting abstract

Antibodies against 25-mer synthetic peptide of M3 muscarinic acetylcholine receptor

P Zigon, A Hocevar, S Cucnik, B Bozic, B Rozman, M Tomsic, T Kveder

Meeting abstract

Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus

A Ambrozic, B Bozic, B Rozman, B Lestan, T Kveder

Meeting abstract

Human cartilage glycoprotein 39-directed T cell responses in health and arthritic diseases

JHM van Bilsen, LR Lard, EIH van der Voort, D Elferink, A Bakker, H van Dongen, AMM Miltenburg, T Huizinga, R de Vries, REM Toes

Meeting abstract

Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice

BF Hoyer, K Moser, AE Hauser, A Peddinghaus, C Voigt, D Eilat, A Radbruch, RA Manz, F Hiepe

Meeting abstract

Differential regulation of the expression of chemokine receptor 3 and 4 during plasma cell differentiation

G Muehlinghaus, L Cigliano, H Leyendeckers, S Arce, A Radbruch, RA Manz

Meeting abstract

Two B cell populations differentially expressing IgVH mRNAs in human RA synovium

S Ruzickova, O Krystufkova, L Sedova, J Niederlova, Z Cimburek, T Dörner, J Vencovsky

Meeting abstract

Immunomics in inflammatory rheumatic diseases

Z Konthur, K Adolph, G Burguera, A Sternjak, A Förster, H Lehrach, GR Burmester, K Skriner

Meeting abstract

VIDAS-EDRA fully automated testing of autoantibodies to citrullinated proteins for the diagnosis of rheumatoid arthritis

L Nogueira, A Foussadier, C Vincent, C Clavel, N Moinard, M Jolivet, G Serre

Meeting abstract

Features of the citrullinating peptidylarginine deiminase enzymes

ER Vossenaar, AJW Zendman, R Raijmakers, TJ Welting, A van der Heijden, WAM Horstman, JH Vogelzangs, S Nijenhuis, WJ van Venrooij, GJM Pruijn

Meeting abstract

False positivity of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus

IEA Hoffman, I Peene, A Union, L Meheus, T Huizinga, L Cebecauer, D Isenberg, K De Bosschere, F Hulstaert, EM Veys, F De Keyser

Meeting abstract

Diagnostic performance and predictive value of serum markers for the diagnosis of rheumatoid arthritis

IEA Hoffman, I Peene, A Union, L Meheus, L De Clercq, L Schatteman, S Poriau, H Mielants, EM Veys, F De Keyser

Meeting abstract

Citrullinated proteins in arthritis: presence in joints and effects on immunogenicity

K Lundberg, S Nijenhuis, E Vossenaar, L Klareskog, WJ van Venrooij, H Erlandsson Harris

Meeting abstract

The presence of deiminated fibrin in the synovial membrane is not specific for rheumatoid arthritis

S Chapuy-Regaud, M Sebbag, D Baeten, C Clavel, F De Keyser, G Serre

Meeting abstract

The rheumatoid arthritis specific Sa antigen is citrullinated vimentin

ER Vossenaar, N Depres, M Lora, A van der Heijden, E Lapointe, AJW Zendman, T Senshu, WJ van Venrooij, HA Ménard

Meeting abstract

Elevated expression of IL-18 in Sjögren's syndrome: distinct expression patterns of the active and proactive forms

S Boiu-Zahiu, EK Kapsogeorgou, ID Dimitriou, MP Spahidou, HM Moutsopoulos, MN Manoussakis

Meeting abstract

Cytokine imbalance in NZB/W mice is associated with autoantibody levels and nephritis

P Enghard, D Langnickel, F Hiepe, GR Burmester, G Riemekasten

Meeting abstract

Anti-tumour necrosis factor therapy modulates the OPG/OPGL system in rheumatoid arthritis synovium

AI Catrina, S Ernestam, E af Klint, L Klareskog, AK Ulfgren

Meeting abstract

IL-20 is expressed in inflamed synovium of patients with psoriatic arthritis and rheumatoid arthritis

TJM Smeets, Y Chandrasekher, JJ Haringman, PP Tak

Meeting abstract

Effects of reduced ATP-formation on cytokine production and proliferation in human peripheral CD4+ T cells

R Tripmacher, T Gaber, GR Burmester, A Radbruch, A Scheffold

Meeting abstract

Intra-articular steroid treatment reduces synovial HMGB1 but not IL-1 expression in chronic arthritis

C Grundtman, E af Klint, U Andersson, L Klareskog, A Ulfgren

Meeting abstract

Human adipose tissue: an important novel source of IL-1Ra

J-M Dayer, C Meier

Meeting abstract

IL-1-dependent cartilage damage in a macrophage-driven arthritis model can be circumvented by T cell IL-17

MI Koenders, E Lubberts, LAB Joosten, JK Kolls, WB van den Berg

Meeting abstract

IL-13 overexpression during immune complex arthritis diminishes MMP-mediated VDIPEN expression

KC Nabbe, PL van Lent, AE Holthuysen, AE Koch, WB van den Berg

Meeting abstract

Overexpression of TNF causes bilateral sacroiliitis

K Redlich, B Görtz, S Hayer, J Zwerina, G Kollias, G Steiner, JS Smolen, G Schett

Meeting abstract

Characterization of the T cell response to hnRNP-A2 (RA33) in HLA-DR4 transgenic mice

M Hoffmann, S Trembleau, S Hayer, JS Smolen, G Steiner

Meeting abstract

Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCP) affects severity of rheumatoid arthritis

FA van Gaalen, J van Aken, TWJ Huizinga, GMTh Schreuder, FC Breedveld, E Zanelli, WJ van Venrooij, CL Verweij, RRP de Vries, REM Toes

Meeting abstract

HLA-DRB1 encoded predisposition to rheumatoid arthritis: the anchor hypothesis

N de Vries, H Tijssen, PLCM van Riel, LBA van de Putte, PP Tak

Meeting abstract

Influence of the physicochemical properties of the HLA-DRB1 shared epitope negative alleles on rheumatoid arthritis susceptibility

L Michou, E Petit-Teixeira, I Lemaire, C Pierlot, J Osorio, W Frigui, S Lasbleiz, P Quillet, T Bardin, B Prum, F Cornélis

Meeting abstract

CD28nullCD4+ T cells: an effector memory T cell population in patients with rheumatoid arthritis

AER Fasth, D Cao, R van Vollenhoven, C Trollmo, V Malmström

Meeting abstract

T cell response in Shigella-induced reactive arthritis

H Brandt, U Stelzl, W Kuon, T Adam, KH Nierhaus, J Sieper

Meeting abstract

CD25+regulatory T cells can be used therapeutically in collagen-induced arthritis

ME Morgan, R Flierman, HJ Witteveen, TWJ Huizinga, RRP de Vries, REM Toes

Meeting abstract

Characterization of kidney infiltrating T cells in the NZB/W F1 lupus model

P Enghard, D Langnickel, GR Burmester, F Hiepe, A Radbruch, G Riemekasten

Meeting abstract

CD25brightCD4+ regulatory T cells accumulate in inflamed joints of patients with chronic rheumatic disease

D Cao, R van Vollenhoven, L Klareskog, C Trollmo, V Malmström

Meeting abstract

Increased expression of chemokines DC-CK1, ELC and TARC by dendritic cells and in synovium from patients with rheumatoid arthritis

T Radstake, R van der Voort, A Sloetjes, C Figdor, W van den Berg, P Barrera, G Adema

Meeting abstract

Characterization of BDCA1 and BDCA4 dendritic cell subsets in rheumatoid arthritis patients

MC Lebre, SW Tas, P Reinders-Blankert, TJM Smeets, PP Tak

Meeting abstract

Triggering of FcGR during dendritic cell maturation leads to a decreased expression of the chemokines DC-CK1, ELC and TARC

TRDJ Radstake, R van der Voort, C Figdor, W van den Berg, P Barrera, GJ Adema

Meeting abstract

Vaccination with TNF-α modulated DCs protects against CIA in an antigen-specific manner

LM van Duivenvoorde, P Louis-Plence, F Apparailly, EIH van der Voort, TJW Huizinga, C Jorgensen, REM Toes

Meeting abstract

The effects of NF-κB inhibition by a NEMO binding domain peptide in vitro and in vivo

SW Tas, EC de Jong, MJ Vervoordeldonk, KA Reedquist, M May, S Ghosh, PP Tak

Meeting abstract

CD44 regulates bone erosion and osteoclastogenesis in arthritis

S Hayer, B Goertz, J Zwerina, K Redlich, O Hoffmann, M Amling, F Hilberg, G Kollias, G Steiner, EF Wagner, JS Smolen, G Schett

Meeting abstract

Differential gene expression and protein expression levels of MMP and TIMP molecules in response to glucocorticoid treatment in arthritic patients

T Andersson, E af Klint, S Strobel, U Andersson, A Stark, R Gelinas, J Lundeberg, L Klareskog, A-K Ulfgren

Meeting abstract

Local interferon-β gene therapy ameliorates adjuvant arthritis in rats

P Adriaansen, J Van Holten, C Kaynor, MJ Vervoordeldonk, PP Tak

Meeting abstract

Neutralizing synovial RANKL by local OPG gene therapy in collagen-induced arthritis prevents cartilage erosion through induction of a non-destructive type 2 synovitis

E Lubberts, MI Koenders, B Oppers-Walgreen, M Wagenmans, L van den Bersselaar, LAB Joosten, J Schurr, JK Kolls, WB van den Berg

Meeting abstract

Human bone marrow-derived mesenchymal stem cells: studies on chondrogenic differentiation, chemotaxis and recruitment

J Ringe, S Straßburg, M Endres, M Notter, T Haeupl, R Manz, C Kaps, M Sittinger

Meeting abstract

Requirement of local synovial IL-17 receptor signaling in the progression of chronic synovitis and bone erosion in arthritis

E Lubberts, W Huang, P Schwarzenberger, J Schurr, J Peschon, WB van den Berg, JK Kolls

Meeting abstract

Expression of TRAIL-R2 (DR5) on fibroblasts from synovial fluid of rheumatoid arthritis

E Miranda, A Balsa, M Benito, C Pérez de Ayala, E Martín-Mola

Meeting abstract

Protection of inflammation-related bone loss by OPG and TNF-α antibodies through distinct mechanisms in collagen-induced arthritis

N Saidenberg-Kermanach, A Corrado, N Bessis, D Lemeiter, MC de Vernejoul, MC Boissier, M Cohen-Solal

Meeting abstract

Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-TNF in combination with OPG or PTH in TNF-mediated arthritis

K Redlich, B Görtz, S Hayer, J Zwerina, N Doerr, P Kostenuik, G Kollias, G Steiner, JS Smolen, G Schett

Meeting abstract

Differential expression and response to infliximab treatment of specific macrophage subsets in inflammatory synovitis

L De Rycke, D Baeten, D Foell, E Kruithof, EM Veys, J Roth, F De Keyser

Meeting abstract

Involvement of SUMO-1 in the regulation of apoptosis in prosthesis loosening fibroblasts

I Meinecke, A Wille, A Cinski, W Neumann, B Ink, R Hay, S Gay, T Pap

Meeting abstract

Monocyte-specific gene signatures in rheumatoid arthritis

A Grützkau, J Grün, M Rudwaleit, L Goldschmidt, G-R Burmester, A Radbruch, T Häupl

Meeting abstract

A customized monocyte cDNA microarray for diagnosis of rheumatoid arthritis and prognosis of anti-TNF-α therapy

B Stuhlmüller, N Tandon, C Hultschig, RJ Kuban, M Hernandez, GR Burmester, T Häupl

Meeting abstract

Reporter cell lines for real-time imaging of NF-κB activation in the arthritic joint

RL Smeets, LAB Joosten, WB van den Berg, FAJ van de Loo

Meeting abstract

Polymorphism at the position -308 of TNF-α gene influences outcome of infliximab therapy in rheumatoid arthritis

B Mugnier, D Reviron, A Darque, N Balandraud, C Roudier, J Roudier

Meeting abstract

Unraveling complexity of rheumatoid synovial gene expression by comparison with purified leukocyte profiles

T Häupl, A Grützkau, J Grün, R Baumgrass, M Janitz, B Stuhlmüller, T Rohrlach, C Kaps, M Rudwaleit, L Morawietz, J Zacher, V Krenn, G-R Burmester, A Radbruch

Meeting abstract

Toll-like receptor 4 polymorphism influences susceptibility to but not severity and outcome of rheumatoid arthritis

TRDJ Radstake, B Franke, S Hanssen, P Welsing, LAB Joosten, PLCM van Riel, P Barrera, WB van den Berg

Meeting abstract

Radiological sacroiliitis is linked with CARD15 gene polymorphisms in patients with Crohn's disease

B Vander Cruyssen, H Peeters, D Laukens, P Coucke, H Mielants, M De Vos, F De Keyser

Meeting abstract

Fibroblast-like synoviocytes derived from patients with rheumatoid arthritis show the imprint of synovial tissue heterogeneity: evidence for the existence of distinctive pathways relevant to disease

PV Kasperkovitz, NL Verbeet, T Smeets, PP Tak, TWJ Huizinga, B Baltus, T Timmer, E Pieterman, M Fero, GS Firestein, AA Alizadeh, TCTM van der Pouw Kraan, CL Verweij

Meeting abstract

Host immune responses to salivary gland administration of recombinant adeno-associated virus serotype 2 vectors

MR Kok, A Voutetakis, S Yamano, J Wang, A Cotrim, H Katano, I Bossis, JA Chiorini, PP Tak, BJ Baum

Meeting abstract

Switching of serotype can improve local AAV-mediated gene therapy in RA

J Adriaansen, M Vervoordeldonk, P Plence, A Bakker, E Gicquel, C Jorgensen, PP Tak, F Apparailly

Meeting abstract

Suppressor of cytokine signaling (SOCS)-3 gene transfer protects against collagen-induced arthritis

FAJ van de Loo, RL Smeets, LAB Joosten, WB van den Berg

Meeting abstract

IL-22 gene transfer in collagen-induced arthritis

F Apparailly, J Dudler, J-C Renauld, P Plence, L Dumoutier, F Djouad, D Noel, AK So, J Sany, C Jorgensen

Meeting abstract

Long-term immune reconstitution in patients treated with autologous stem cell transplantation for refractory autoimmune diseases

T Alexander, G Massenkeil, GR Burmester, A Radbruch, R Arnold, F Hiepe, A Thiel

Meeting abstract

Zoledronic acid protects from local and systemic bone loss in TNF-mediated arthritis

J Zwerina, P Herrak, B Goertz, S Hayer, K Redlich, E Reiter, J Gasser, H Bergmeister, G Kollias, JS Smolen, G Schett

Meeting abstract

Abatacept (CTLA4Ig) treatment increases the remission rate in rheumatoid arthritis patients refractory to methotrexate treatment

R Westhovens, P van Riel, J Sibilia, G Vratsanos, I Nuamah, JC Becker

Meeting abstract

Multidrug resistance proteins and DMARD efficacy in rheumatoid arthritis

G Jansen, R Oerlemans, J van der Heijden, WF Lems, GL Scheffer, RJ Scheper, BAC Dijkmans

Meeting abstract

Impact of cellular therapies on autoreactive, long-lived plasma cells in autoimmune diseases (AID)

F Hiepe, R Manz, B Hoyer, A Thiel, T Alexander, G-R Burmester, G Massenkeil, R Arnold, A Radbruch

Meeting abstract

Addition of cyclosporine-A (Neoral®) in patients on anti-TNF and methotrexate therapy improves disease activity: an open-label, pilot study

P Sidiropoulos, P Siakka, M Mamoulaki, H Kouroumali, H Kritikos, DT Boumpas

Meeting abstract

Effects of anti-TNF therapy on endothelial function and intima–media thickness of common carotid artery in patients with rheumatoid arthritis

P Siakka, A Kalikaki, K Pagonidis, P Sidiropoulos, H Kritikos, E Ganotakis, D Tsetis, DT Boumpas

Meeting abstract

Epstein–Barr virus load follow up in rheumatoid arthritis patients treated with TNF-α inhibitors

N Balandraud, JB Meynard, I Auger, H Sovran, B Mugnier, D Reviron, J Roudier, C Roudier

Meeting abstract

The effect of infliximab on skin lesions in a patient with scleroderma (CREST)

L De Rycke, D Baeten, F Van den Bosch, H Mielants, F De Keyser, EM Veys

Meeting abstract

Cross-reaction between the major epitope of Ro60 protein (pep216–232) and a homologous peptide of Coxsackievirus 3C protease

EA Stathopoulou, JG Routsias, HA Stea, HM Moutsopoulos, AG Tzioufas

Meeting abstract

Aberrant expression of the co-chaperone HDJ2 in rheumatoid arthritis

A Zgaga-Griesz, S Haak, K Retzlaff, C Schick, R Rzepka, I Melchers

Meeting abstract

Effects of anti-rheumatic treatments on expression of microsomal prostaglandin E synthase-1 in rheumatoid arthritis synovium

M Korotkova, M Westman, E af Klint, A-K Ulfgren, L Klareskog, P-J Jakobsson

Meeting abstract

Statins have no effect on collagen-induced arthritis in mice

G Palmer, V Chobaz, D Talabot, S Taylor, A So, C Gabay, N Busso

Meeting abstract

Serum MRP8/MRP14 as a biomarker for inflammation in autoimmune arthritis

L De Rycke, D Baeten, D Foell, E Kruithof, EM Veys, J Roth, F De Keyser

Meeting abstract

The role of a defective clearance in the pathogenesis of systemic lupus erythematosus

S Franz, US Gaipl, U Appelt, P Heyder, RE Voll, JR Kalden, M Herrmann

Meeting abstract

Clinical and serological study of 26 patients with anti-SL (Ki) autoantibodies

I Cavazzana, F Franceschini, C Vassalini, M Quinzanini, L Andreoli, R Cattaneo

Meeting abstract

Drug induced differential gene expression in normal and RA synovial fibroblasts cell lines

M Yahyawi, C Kaps, C Lübke, J Ringe, T Rohrlach, H Augst, G-R Burmester, T Häupl, M Sittinger

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine